PlainRecalls
FDA Drug Moderate Class II Terminated

Lidocaine Hydrochloride Jelly USP, 2%, Sterile, 30mL tube, Rx only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-711-31

Reported: September 14, 2022 Initiated: August 31, 2022 #D-1495-2022

Product Description

Lidocaine Hydrochloride Jelly USP, 2%, Sterile, 30mL tube, Rx only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-711-31

Reason for Recall

cGMP Deviations: Turbidity discovered in Artificial Tears Ointment during sterility testing. Scope expanded to include other lots and products which potentially share the same root cause.

Details

Recalling Firm
Akorn, Inc.
Units Affected
82,689 tubes
Distribution
USA nationwide
Location
Gurnee, IL

Frequently Asked Questions

What product was recalled?
Lidocaine Hydrochloride Jelly USP, 2%, Sterile, 30mL tube, Rx only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-711-31. Recalled by Akorn, Inc.. Units affected: 82,689 tubes.
Why was this product recalled?
cGMP Deviations: Turbidity discovered in Artificial Tears Ointment during sterility testing. Scope expanded to include other lots and products which potentially share the same root cause.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 14, 2022. Severity: Moderate. Recall number: D-1495-2022.